iCAD, Inc. (ICAD) Analysts See $-0.15 EPS

February 15, 2018 - By Migdalia James

 iCAD, Inc. (ICAD) Analysts See $ 0.15 EPS

Analysts expect iCAD, Inc. (NASDAQ:ICAD) to report $-0.15 EPS on March, 14.They anticipate $0.05 EPS change or 25.00 % from last quarter’s $-0.2 EPS. After having $-0.13 EPS previously, iCAD, Inc.’s analysts see 15.38 % EPS growth. The stock decreased 4.56% or $0.15 during the last trading session, reaching $3.14. About 7,382 shares traded. iCAD, Inc. (NASDAQ:ICAD) has declined 14.66% since February 15, 2017 and is downtrending. It has underperformed by 31.36% the S&P500.

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. The company has market cap of $51.85 million. It operates through two divisions, Cancer Detection and Cancer Therapy. It currently has negative earnings. The firm provides electronic brachytherapy products, including Axxent eBx systems for the treatment of early stage breast cancer, endometrial cancer, cervical cancer, and skin cancer, as well as for treating other cancers or conditions where radiation therapy is indicated comprising intraoperative radiation therapy.

More notable recent iCAD, Inc. (NASDAQ:ICAD) news were published by: Seekingalpha.com which released: “iCAD’s (ICAD) CEO Ken Ferry on Q3 2017 Results – Earnings Call Transcript” on November 11, 2017, also Globenewswire.com with their article: “iCAD Announces Approval of Xoft® Axxent® Balloon Applicators by China Food …” published on August 30, 2017, Globenewswire.com published: “iCAD Reports Second Quarter 2017 Financial Results and Announces $13 Million …” on August 08, 2017. More interesting news about iCAD, Inc. (NASDAQ:ICAD) were released by: Globenewswire.com and their article: “iCAD Named a Top Artificial Intelligence Medical Imaging Solution Provider by …” published on February 08, 2018 as well as Globenewswire.com‘s news article titled: “iCAD to Report Second Quarter 2017 Financial Results on Tuesday, August 8” with publication date: July 31, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.